Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XSONX
Charlotte, North Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The XSONX Wound Hygiene System is commercially available and has demonstrated in clinical studies reduced pain and anxiety for patients during wound debridement, better wound bed preparation, and disruption of biofilms. It is positioned as more effective and less painful compared to traditional debridement techniques in chronic wound care.[1][3][5][6]
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Partnerships
Kane BiotechMelling Medical
Beyond the preview
Go deeper on XSONX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XSONX.